Medication
Ended Awarded Last action
- Contract number
- 36C24622N0625
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$11,426 | |
| Original award | $22,839 |
About this award
On April 14, 2022, the Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order contract to Otsuka America Pharmaceutical Inc. for medication supply. This firm-fixed price delivery order, valued at $11,413.72, was executed without a set-aside designation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract calls for performance in Pittsburgh, Pennsylvania, with an ultimate completion date of June 6, 2022. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializes in developing and distributing complex pharmaceutical products to federal healthcare systems.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company maintains substantial indefinite delivery vehicles with the VA, including a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, demonstrating its established capability as a primary supplier of specialized medications to VA facilities across multiple Integrated Service Networks nationwide. This delivery order supports the VA's mission of providing critical pharmaceutical treatments to veterans.
Quick answers
Who was awarded contract 36C24622N0625?
36C24622N0625 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on April 14, 2022.
How much is contract 36C24622N0625 worth?
The government has obligated $11,414 on 36C24622N0625.
Is contract 36C24622N0625 an order under another contract?
Yes. 36C24622N0625 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0625 competed?
The extent of competition for 36C24622N0625 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award